Relationship of Essential Hypertension and Its Treatments on the Postoperative Pain Management: a Prospective, Observational, Cross-sectional Study
1 other identifier
observational
300
1 country
1
Brief Summary
Numbers of postoperative PCA related side effects among three groups will be determined by comparing and analyzing frequency distributions. To determine whether the patients with hypertension require less post operative opiate analgesics than others, multivariate analysis with repeated measures will be performed to identify the major and the minor factors predicting the use of postoperative pain therapy. The major aim of the study is to test the hypothesis that the morphine comsumpted by the hypertension group is less than those of the normotension group. The minor aims for the study are the difference related to pain intensity, or the incidence of side effects among groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2013
CompletedFirst Submitted
Initial submission to the registry
September 10, 2014
CompletedFirst Posted
Study publicly available on registry
September 18, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedApril 1, 2015
March 1, 2015
2.1 years
September 10, 2014
March 30, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Pain
Post-operation Day1 to Day4
Secondary Outcomes (1)
Morphine consumption
Post-operation Day1 to Day4
Other Outcomes (1)
side effects
Post-operation Day1 to Day4
Study Arms (3)
normotension group
Until 11,March, 2015, 31 cases are collected.
hypertension group without treatment
Until 11,March, 2015, 60 cases are collected.
hypertension group with antihypertensive treatment
(ACEI, beta-blocker, Ca blocker, Diuretics) prior to the surgery. Until 11,March, 2015, 59 cases are collected.
Eligibility Criteria
Those patients enrolled will be divided into three groups as follows As the treatment and choice of drugs for hypertension is complex but internation guideline-oriented. We would like to enroll enough sample size in the hypertensive groups and subgroups. 1. Normaltension group (control group) 2. Hypertension without treatment 3. Hypertension with treatment as follows (according to subject's daily routine Tx, the PI not involved into the choice and further manitence of drugs) I. Hypertension with treatment with ACEI II. Hypertension with treatment with β blocker III. Hypertension with treatment with Ca channel blocker IV. Hypertension with treatment with diuretics
You may qualify if:
- eligible subjects
- No contraindication for inhalation anesthesia
- Elective surgery
- Age between 20-75 y/o
- No contraindication for postoperative morphine pain control
- Female or male
- Essential hypertension stage I and II (140\<=SBP\<=180; 90\<=DBP\<=110)
You may not qualify if:
- Liver disease
- Renal disease
- Those who is presumed to go to ICU after surgery
- The patients with dementia or conscious disturbance
- Pregnancy or breast feeding
- Secondary hypertension
- events in recent 6 months myocardial infarction cardiac bypass surgery unstable angina cerebrovascular events congestive heart failure significant arrhythmia thoracic surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kaohsiung Veterans General Hospital
Kaohsiung City, 81362, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- anesthesia doctor
Study Record Dates
First Submitted
September 10, 2014
First Posted
September 18, 2014
Study Start
November 1, 2013
Primary Completion
December 1, 2015
Last Updated
April 1, 2015
Record last verified: 2015-03